We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byKatrina Judith Walters
Modified over 4 years ago
Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer Talha Shaikh, MD, Karen Ruth, MS, Walter J. Scott, MD, Barbara A. Burtness, MD, Steven J. Cohen, MD, Andre A. Konski, MD, Harry S. Cooper, MD, Igor Astsaturov, MD, Joshua E. Meyer, MD The Annals of Thoracic Surgery Volume 99, Issue 1, Pages (January 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Elapsed time (days) from neoadjuvant chemoradiation treatment (NCRT) to surgery. (n = 88; mean 57.1, median 50.5, minimum 26, maximum 204.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Pathologic response (light blue, residual; medium blue, microfoci; dark blue, pathologic complete response [pCR]) by interval from end of chemoradiation therapy (CRT) to surgery by (A) quartile and (B) 3-week interval group. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier plots for overall survival by interval quartile (Q): I (lime-green), II (green), III (blue), and IV (purple). (Num. = number.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Photodynamic Laser Therapy for Lesions in the Airway
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,
Elizabeth A. David, MD, David T
Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer
Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer Yoichi.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter,
Joshua E. Rosen, BASc, Hari B
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD
Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis Andrew J. Graham, MD, MS, Fiona M. Shrive,
Arjun Pennathur, MD, Andrew C. Chang, MD, Kevin M
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy
Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy Sang Kuon Lee, MD, Jongho Lee, MD The Annals.
© 2023 SlidePlayer.com Inc. All rights reserved.